Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IL › CHICAGO › SHAHEN, SAMIR

SHAHEN, SAMIR

NPI: 1558773663 · CHICAGO, IL 60622 · Family Medicine Physician · NPI assigned 05/22/2014

$2.09M
Total Medicaid Paid
46,059
Total Claims
34,328
Beneficiaries
48
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,259 $19K
2019 3,445 $58K
2020 3,335 $89K
2021 4,324 $207K
2022 10,260 $496K
2023 14,034 $678K
2024 9,402 $539K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14,839 10,967 $733K
95144 685 110 $225K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,739 2,228 $205K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4,326 4,102 $204K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,238 2,779 $161K
99233 Prolong inpt eval add15 m 2,028 899 $75K
99232 Subsequent hospital care, per day, moderate complexity 3,243 1,779 $72K
99309 Subsequent nursing facility care, per day, low to moderate complexity 2,880 985 $63K
99238 Hospital discharge day management, 30 minutes or less 1,641 1,434 $42K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,764 1,608 $41K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 311 133 $40K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,442 2,295 $36K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 351 333 $33K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 346 326 $27K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 513 194 $25K
95923 222 207 $16K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 169 168 $14K
95924 120 114 $10K
99215 Prolong outpt/office vis 133 105 $10K
99384 81 81 $9K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 103 103 $8K
93923 144 132 $8K
95921 107 97 $5K
99223 Prolong inpt eval add15 m 46 44 $5K
99383 35 35 $3K
81025 466 414 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 28 27 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 221 158 $2K
99222 Initial hospital care, per day, moderate complexity 43 42 $2K
81002 534 476 $1K
96127 93 82 $1K
99205 Prolong outpt/office vis 13 13 $1K
99231 Subsequent hospital care, per day, straightforward or low complexity 92 80 $1K
94761 56 51 $820.80
99239 Hospital discharge day management, more than 30 minutes 14 14 $743.98
93040 88 80 $640.61
99051 1,088 903 $268.59
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 20 19 $263.79
81003 95 87 $189.90
81001 56 47 $157.81
86580 15 14 $92.27
94760 12 12 $48.40
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 24 13 $31.35
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 19 18 $2.36
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 114 111 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 17 14 $0.00
G8509 Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given 27 17 $0.00
G8732 No documentation of pain assessment, reason not given 418 378 $0.00